Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Insomnia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global insomnia market size reached US$ 4.87 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.93 Billion by 2027, exhibiting a growth rate (CAGR) of 3.22% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.

Insomnia Market Trends:

The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global insomnia market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapy type, drug class and distribution channel.

Breakup by Therapy Type:

  • Non-Pharmacological Therapy
    • Hypnotherapy
    • Cognitive Behavioral Therapy
    • Medical Devices
    • Others
  • Pharmacological Therapy
    • Prescription Sleep Aids
    • Over-The-Counter Sleep Aids
       

Breakup by Drug Class:

  • Antidepressants
  • Melatonin Antagonist
  • Benzodiazepines
  • Nonbenzodiazepines
  • Orexin Antagonist
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Therapy Type, Drug Class, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global insomnia market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global insomnia market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapy type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global insomnia market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Insomnia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Therapy Type
    6.1    Non-Pharmacological Therapy
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Hypnotherapy
           6.1.2.2 Cognitive Behavioral Therapy
           6.1.2.3 Medical Devices
           6.1.2.4 Others
        6.1.3 Market Forecast
    6.2    Pharmacological Therapy
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Prescription Sleep Aids
           6.2.2.2 Over-The-Counter Sleep Aids
        6.2.3 Market Forecast
7    Market Breakup by Drug Class
    7.1    Antidepressants
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Melatonin Antagonist
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Benzodiazepines
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Nonbenzodiazepines
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Orexin Antagonist
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Drug Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Online Pharmacies
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Astellas Pharma Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Aurobindo Pharma Limited
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Biocodex
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Eisai Co. Ltd.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Mallinckrodt Pharmaceuticals
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Neurim Pharmaceuticals Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Vanda Pharmaceuticals Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials

List of Figures

Figure 1: Global: Insomnia Market: Major Drivers and Challenges
Figure 2: Global: Insomnia Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2021
Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2021
Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Insomnia Industry: SWOT Analysis
Figure 82: Global: Insomnia Industry: Value Chain Analysis
Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Insomnia Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million US$), 2022-2027
Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Insomnia Market: Competitive Structure
Table 7: Global: Insomnia Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links